15-hydroxy Lubiprostone

Cat Number
API475992304
CAS Number
475992-30-4

If you have any other questions, please contact our experts.

CAS Number
475992-30-4
Storage
Powder: -20℃ for 3 years. In solvent: -80℃ for 1 year.
Description
15-hydroxy Lubiprostone, synthesized through cyclooxygenase-mediated metabolism of dihomo-γ-linolenic acid (DGLA), functions by inhibiting platelet aggregation (IC50= 40 nM) and enhancing vasodilation. Its analog, 13,14-dihydro-16,16-difluoro PGE1, and the metabolite, 13,14-dihydro PGE1, both retain similar anti-aggregatory properties to the original compound. The inclusion of two electron-withdrawing fluorine atoms in 13,14-dihydro-16,16-difluoro PGE1 is believed to increase molecular stability and potentially extend bioavailability by resisting hydrolytic degradation.
Molecular Formula
C20H34F2O5
Molecular Weight
392.484
You Might Also Like
Dacomitinib metabolite M2
Dacomitinib metabolite M2

Cat NO.: API1262034387
CAS NO.: 1262034-38-7

View Details
Fluphenazine dihydrochloride
Fluphenazine dihydrochloride

Cat NO.: API146565
CAS NO.: 146-56-5

View Details
Deferasirox
Deferasirox

Cat NO.: API201530418
CAS NO.: 201530-41-8

View Details
Seladelpar
Seladelpar

Cat NO.: API851528795
CAS NO.: 851528-79-5

View Details
HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

Member of
dcat
CERTIFICATION
dcat
dcat dcat dcat dcat
Contact Us
USA

Tel:
Email:
Address:

 
Denmark

Tel:
Email:
Address:

WhatsAPP
WhatsAPP (Sales #1)
WhatsAPP
WhatsAPP (Sales #2)
WhatsAPP
WhatsAPP (Sales #3)
Privacy Policy | Cookie Policy
Copyright © Protheragen. All Rights Reserved.

WhatsAPP
Top